From: Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patients
 | CRF02_AG | Subtype B | Subtype A | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | OR | 95% CI | ||||
Lower | Upper | Lower | Upper | Lower | Upper | ||||
Age group (years) | |||||||||
 <20 | 2.3 | 1.34 | 2.62 | 0.60 | 0.35 | 0.95 | 0.0 | 0.0 | 0.0 |
 21–40 | 0.20 | 0.09 | 0.24 | 2.89 | 1.95 | 3.95 | 0.70 | 0.43 | 1.02 |
 >40 | 0.0 | 0.0 | 0.0 | 2.91 | 2.21 | 3.9 | 0.59 | 0.39 | 0.91 |
Sex | |||||||||
 M vs. F | 0.75 | 0.63 | 0.89 | 1.71 | 1.68 | 1.98 | 1.62 | 1.46 | 1.79 |
Risk factors | |||||||||
 Blood transfusion | 1.22 | 1.12 | 1.87 | 0.3 | 0.12 | 0.34 | 0 | 0 | 0 |
 IVDU | 0.0 | 0.0 | 0.0 | 6.31 | 2.15 | 17.15 | 5.65 | 1.75 | 17.06 |
 Sexual contact | 0.0 | 0.0 | 0.0 | 1.21 | 1.05 | 1.43 | 0 | 0 | 0 |
 Vertical transmission | 0.9 | 0.8 | 1.90 | 0 | 0 | 0 | 0 | 0 | 0 |
Screening period | |||||||||
 1995–2000 | 1.06 | 0.8 | 2.4 | 1.9 | 0.6 | 3.4 | 0.0 | 0.0 | 0.0 |
 2001–2005 | 0.02 | 0.01 | 1.02 | 2.7 | 1.2 | 5.6 | 0.01 | 0.01 | 0.01 |
 2006–2010 | 0.01 | 0.0 | 0.42 | 4.1 | 2.2 | 6.8 | 0.01 | 0.01 | 0.04 |